Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy

A Vezzani, S Balosso, T Ravizza - Nature Reviews Neurology, 2019 - nature.com
Epilepsy is a chronic neurological disease characterized by an enduring propensity for
generation of seizures. The pathogenic processes of seizure generation and recurrence are …

Extracellular HMGB1 as a therapeutic target in inflammatory diseases

U Andersson, H Yang, H Harris - Expert opinion on therapeutic …, 2018 - Taylor & Francis
Introduction: High-mobility group box 1 (HMGB1) is a ubiquitous nuclear protein that
promotes inflammation when released extracellularly after cellular activation, stress …

Commonalities in epileptogenic processes from different acute brain insults: Do they translate?

P Klein, R Dingledine, E Aronica, C Bernard… - …, 2018 - Wiley Online Library
The most common forms of acquired epilepsies arise following acute brain insults such as
traumatic brain injury, stroke, or central nervous system infections. Treatment is effective for …

Metabolic dysfunction and oxidative stress in epilepsy

JN Pearson-Smith, M Patel - International Journal of Molecular Sciences, 2017 - mdpi.com
The epilepsies are a heterogeneous group of disorders characterized by the propensity to
experience spontaneous recurrent seizures. Epilepsies can be genetic or acquired, and the …

Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies

EA van Vliet, E Aronica, A Vezzani… - Neuropathology and …, 2018 - Wiley Online Library
Accumulating evidence indicates an important pathophysiological role of brain inflammation
in epilepsy. In this review, we will provide an update of specific inflammatory pathways that …

Emerging promise of sulforaphane-mediated Nrf2 signaling cascade against neurological disorders

MS Uddin, A Al Mamun, M Jakaria… - Science of the Total …, 2020 - Elsevier
Neurological disorders represent a great challenge and are the leading cause of death and
disability globally. Although numerous complicated mechanisms are involved in the …

Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling

YN Paudel, E Angelopoulou, C Piperi… - European journal of …, 2019 - Elsevier
High mobility group box 1 (HMGB1) is a ubiquitous protein, released passively by necrotic
tissues or secreted actively by stressed cells. Extracellular HMGB1 is a typical damage …

Modulating neuroinflammation and oxidative stress to prevent epilepsy and improve outcomes after traumatic brain injury

CL Eastman, R D'Ambrosio, T Ganesh - Neuropharmacology, 2020 - Elsevier
Traumatic brain injury (TBI) is a leading cause of death and disability in young adults
worldwide. TBI survival is associated with persistent neuropsychiatric and neurological …

The holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments

W Löscher - Neuropharmacology, 2020 - Elsevier
A variety of acute brain insults can induce epileptogenesis, a complex process that results in
acquired epilepsy. Despite advances in understanding mechanisms of epileptogenesis …

Baicalein Exerts Neuroprotective Effects in FeCl3-Induced Posttraumatic Epileptic Seizures via Suppressing Ferroptosis

Q Li, QQ Li, JN Jia, QY Sun, HH Zhou, WL Jin… - Frontiers in …, 2019 - frontiersin.org
Posttraumatic epilepsy (PTE) is a prevalent type of acquired epilepsy secondary to traumatic
brain injury, and is characterized by repeated seizures. Traditional antiepileptic drugs have …